Vbi Vaccines Stock Market Value
VBIVQ Stock | 0.0005 0.0001 16.67% |
Symbol | VBI |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VBI Vaccines. If investors know VBI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VBI Vaccines listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of VBI Vaccines is measured differently than its book value, which is the value of VBI that is recorded on the company's balance sheet. Investors also form their own opinion of VBI Vaccines' value that differs from its market value or its book value, called intrinsic value, which is VBI Vaccines' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VBI Vaccines' market value can be influenced by many factors that don't directly affect VBI Vaccines' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VBI Vaccines' value and its price as these two are different measures arrived at by different means. Investors typically determine if VBI Vaccines is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VBI Vaccines' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
VBI Vaccines 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to VBI Vaccines' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of VBI Vaccines.
01/05/2023 |
| 12/25/2024 |
If you would invest 0.00 in VBI Vaccines on January 5, 2023 and sell it all today you would earn a total of 0.00 from holding VBI Vaccines or generate 0.0% return on investment in VBI Vaccines over 720 days. VBI Vaccines is related to or competes with Kura Sushi, Awilco Drilling, Transocean, Westrock Coffee, Patterson UTI, Cannae Holdings, and Dominos Pizza. More
VBI Vaccines Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure VBI Vaccines' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess VBI Vaccines upside and downside potential and time the market with a certain degree of confidence.
Information Ratio | (0.04) | |||
Maximum Drawdown | 177.78 | |||
Value At Risk | (50.00) | |||
Potential Upside | 60.0 |
VBI Vaccines Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for VBI Vaccines' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as VBI Vaccines' standard deviation. In reality, there are many statistical measures that can use VBI Vaccines historical prices to predict the future VBI Vaccines' volatility.Risk Adjusted Performance | (0.02) | |||
Jensen Alpha | (1.27) | |||
Total Risk Alpha | (2.55) | |||
Treynor Ratio | (1.70) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of VBI Vaccines' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
VBI Vaccines Backtested Returns
VBI Vaccines owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0415, which indicates the company had a -0.0415% return per unit of volatility over the last 3 months. VBI Vaccines exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate VBI Vaccines' Standard Deviation of 29.85, risk adjusted performance of (0.02), and Market Risk Adjusted Performance of (1.69) to confirm the risk estimate we provide. The firm has a beta of 0.73, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, VBI Vaccines' returns are expected to increase less than the market. However, during the bear market, the loss of holding VBI Vaccines is expected to be smaller as well. At this point, VBI Vaccines has a negative expected return of -1.24%. Please make sure to validate VBI Vaccines' jensen alpha, skewness, as well as the relationship between the Skewness and day typical price , to decide if VBI Vaccines performance from the past will be repeated at future time.
Auto-correlation | 0.56 |
Modest predictability
VBI Vaccines has modest predictability. Overlapping area represents the amount of predictability between VBI Vaccines time series from 5th of January 2023 to 31st of December 2023 and 31st of December 2023 to 25th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of VBI Vaccines price movement. The serial correlation of 0.56 indicates that roughly 56.0% of current VBI Vaccines price fluctuation can be explain by its past prices.
Correlation Coefficient | 0.56 | |
Spearman Rank Test | 0.74 | |
Residual Average | 0.0 | |
Price Variance | 0.09 |
VBI Vaccines lagged returns against current returns
Autocorrelation, which is VBI Vaccines stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting VBI Vaccines' stock expected returns. We can calculate the autocorrelation of VBI Vaccines returns to help us make a trade decision. For example, suppose you find that VBI Vaccines has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
VBI Vaccines regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If VBI Vaccines stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if VBI Vaccines stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in VBI Vaccines stock over time.
Current vs Lagged Prices |
Timeline |
VBI Vaccines Lagged Returns
When evaluating VBI Vaccines' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of VBI Vaccines stock have on its future price. VBI Vaccines autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, VBI Vaccines autocorrelation shows the relationship between VBI Vaccines stock current value and its past values and can show if there is a momentum factor associated with investing in VBI Vaccines.
Regressed Prices |
Timeline |
Pair Trading with VBI Vaccines
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if VBI Vaccines position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VBI Vaccines will appreciate offsetting losses from the drop in the long position's value.Moving against VBI Stock
0.57 | EPRX | Eupraxia Pharmaceuticals | PairCorr |
0.44 | FRTX | Fresh Tracks Therapeutics | PairCorr |
0.4 | FBIOP | Fortress Biotech Pref | PairCorr |
0.33 | UPB | Upstream Bio, | PairCorr |
The ability to find closely correlated positions to VBI Vaccines could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace VBI Vaccines when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back VBI Vaccines - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling VBI Vaccines to buy it.
The correlation of VBI Vaccines is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as VBI Vaccines moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if VBI Vaccines moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for VBI Vaccines can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for VBI Stock Analysis
When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.